The post Ripple, leading VCs invest in OpenEden to support the real-world asset tokenisation firm’s expansion appeared on BitcoinEthereumNews.com. The company will focus on scaling TBILL and the yield-bearing stablecoin USDO. cUSDO was approved this year as off-exchange collateral at Binance. BNY Mellon now manages and safeguards Treasurys underlying TBILL. Real-world asset tokenisation is becoming one of crypto’s most active areas in 2025, and OpenEden is positioning itself at the centre of this shift with a new round of investment supported by major industry players. The company confirmed on Tuesday that leading trading firms, venture capital groups, blockchain networks and institutional infrastructure providers have backed its latest raise to expand access to tokenised US Treasurys. The round, which follows OpenEden’s 2024 raise with YZi Labs, comes at a time when short-dated government debt has emerged as one of the fastest-growing niches in digital assets as institutions look for familiar, regulated yields on-chain. Tokenisation demand drives new investment push OpenEden said the fresh capital will help it scale its tokenisation-as-a-service platform as more institutions look to move traditional assets onto public blockchains. The firm is leaning into rising demand for regulated products tied to government debt, with short-term Treasurys becoming a preferred entry point for investors seeking on-chain yield that mirrors conventional markets. The company did not disclose the size of the round, but it confirmed participation from Ripple, Lightspeed Faction, Gate Ventures, FalconX, Anchorage Digital Ventures, Flowdesk, P2 Ventures, Selini Capital, Kaia Foundation, and Sigma Capital. Expansion of TBILL and USDO across markets A significant portion of upcoming development will centre on OpenEden’s two main offerings: TBILL, its tokenised US Treasury fund, and USDO, a stablecoin backed by those same Treasurys. USDO and its wrapped version, cUSDO, have already been integrated across decentralised exchanges and lending markets. Earlier this year, Binance authorised cUSDO as off-exchange collateral. OpenEden said the new investment will support broader distribution of these products and allow the company to introduce additional market structures tied to real-world financial assets.… The post Ripple, leading VCs invest in OpenEden to support the real-world asset tokenisation firm’s expansion appeared on BitcoinEthereumNews.com. The company will focus on scaling TBILL and the yield-bearing stablecoin USDO. cUSDO was approved this year as off-exchange collateral at Binance. BNY Mellon now manages and safeguards Treasurys underlying TBILL. Real-world asset tokenisation is becoming one of crypto’s most active areas in 2025, and OpenEden is positioning itself at the centre of this shift with a new round of investment supported by major industry players. The company confirmed on Tuesday that leading trading firms, venture capital groups, blockchain networks and institutional infrastructure providers have backed its latest raise to expand access to tokenised US Treasurys. The round, which follows OpenEden’s 2024 raise with YZi Labs, comes at a time when short-dated government debt has emerged as one of the fastest-growing niches in digital assets as institutions look for familiar, regulated yields on-chain. Tokenisation demand drives new investment push OpenEden said the fresh capital will help it scale its tokenisation-as-a-service platform as more institutions look to move traditional assets onto public blockchains. The firm is leaning into rising demand for regulated products tied to government debt, with short-term Treasurys becoming a preferred entry point for investors seeking on-chain yield that mirrors conventional markets. The company did not disclose the size of the round, but it confirmed participation from Ripple, Lightspeed Faction, Gate Ventures, FalconX, Anchorage Digital Ventures, Flowdesk, P2 Ventures, Selini Capital, Kaia Foundation, and Sigma Capital. Expansion of TBILL and USDO across markets A significant portion of upcoming development will centre on OpenEden’s two main offerings: TBILL, its tokenised US Treasury fund, and USDO, a stablecoin backed by those same Treasurys. USDO and its wrapped version, cUSDO, have already been integrated across decentralised exchanges and lending markets. Earlier this year, Binance authorised cUSDO as off-exchange collateral. OpenEden said the new investment will support broader distribution of these products and allow the company to introduce additional market structures tied to real-world financial assets.…

Ripple, leading VCs invest in OpenEden to support the real-world asset tokenisation firm’s expansion

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
  • The company will focus on scaling TBILL and the yield-bearing stablecoin USDO.
  • cUSDO was approved this year as off-exchange collateral at Binance.
  • BNY Mellon now manages and safeguards Treasurys underlying TBILL.

Real-world asset tokenisation is becoming one of crypto’s most active areas in 2025, and OpenEden is positioning itself at the centre of this shift with a new round of investment supported by major industry players.

The company confirmed on Tuesday that leading trading firms, venture capital groups, blockchain networks and institutional infrastructure providers have backed its latest raise to expand access to tokenised US Treasurys.

The round, which follows OpenEden’s 2024 raise with YZi Labs, comes at a time when short-dated government debt has emerged as one of the fastest-growing niches in digital assets as institutions look for familiar, regulated yields on-chain.

Tokenisation demand drives new investment push

OpenEden said the fresh capital will help it scale its tokenisation-as-a-service platform as more institutions look to move traditional assets onto public blockchains.

The firm is leaning into rising demand for regulated products tied to government debt, with short-term Treasurys becoming a preferred entry point for investors seeking on-chain yield that mirrors conventional markets.

The company did not disclose the size of the round, but it confirmed participation from Ripple, Lightspeed Faction, Gate Ventures, FalconX, Anchorage Digital Ventures, Flowdesk, P2 Ventures, Selini Capital, Kaia Foundation, and Sigma Capital.

Expansion of TBILL and USDO across markets

A significant portion of upcoming development will centre on OpenEden’s two main offerings: TBILL, its tokenised US Treasury fund, and USDO, a stablecoin backed by those same Treasurys.

USDO and its wrapped version, cUSDO, have already been integrated across decentralised exchanges and lending markets.

Earlier this year, Binance authorised cUSDO as off-exchange collateral.

OpenEden said the new investment will support broader distribution of these products and allow the company to introduce additional market structures tied to real-world financial assets.

Broader product pipeline builds institutional focus

Beyond Treasurys, OpenEden is preparing several new instruments designed to deepen institutional engagement with tokenised markets.

These include upcoming tokenised bond exposure, a multi-strategy yield token and a range of structured products aimed at investors familiar with traditional income-generating instruments.

In August, the company appointed BNY Mellon as custodian and investment manager for the Treasurys underlying TBILL.

The product has also received investment-grade ratings from S&P Global and Moody’s, marking a notable step in bridging conventional market requirements with decentralised finance infrastructure.

Source: https://coinjournal.net/news/ripple-leading-vcs-invest-in-openeden-to-support-the-real-world-asset-tokenisation-firms-expansion/

Market Opportunity
RealLink Logo
RealLink Price(REAL)
$0,06206
$0,06206$0,06206
+%3,27
USD
RealLink (REAL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
Why YouCam AI API is the Secret Weapon for E-Commerce Startups

Why YouCam AI API is the Secret Weapon for E-Commerce Startups

 The New Standard of Personalized Shopping In an era where digital engagement dictates market share, the transition from “browsing” to “buying” depends on confidence
Share
Techbullion2026/03/25 14:34
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26